Tradestie Institutional Equity Comparison Engine

CRMD vs NRIX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NRIX Overall Edge

NRIX Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nurix Therapeutics, Inc. Common stock (NRIX) driven by superior Growth & Margin, Momentum & Technical while CRMD counters with relative strength in Valuation, Options & Structure. Fundamentally, CRMD trades at 49.0x Forward P/E with 41.0% operating margin (-47.7% YoY revenue) versus NRIX at N/M Forward P/E and 41.3% operating margin (+8426.3% YoY). In options structure, CRMD sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro) against NRIX sits in BREAKDOWN (4th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CRMD
CRMD 49.0x vs NRIX N/M Fwd P/E
Growth & Margin Winner NRIX
Op Margin 41.0% vs 41.3% ยท YoY -47.7% vs +8426.3%
Momentum & Technical Winner NRIX
1Y -56.2% vs +20.8% ยท 52W Pos 3% vs 18%
Options & Structure Winner CRMD
BREAKDOWN (25th %ile IV) vs BREAKDOWN (4th %ile IV)
CRMD NASDAQ
CorMedix Inc.
Pharmaceutical Preparations
$4.92
+5.47% 1D
Market Cap $384.7M
1M Return -32.3%
1Y Return -56.16%
Forward P/E 49.0x
Unified AI Score
53.2 / 100 HOLD
Tech 60.0 Fund 60.0 Flow 69.0 Mom 55.0
NRIX NASDAQ
Nurix Therapeutics, Inc. Common stock
Pharmaceutical Preparations
$15.01
-3.04% 1D
Market Cap $1.7B
1M Return -38.53%
1Y Return +20.76%
Forward P/E N/M
Unified AI Score
51.5 / 100 HOLD
Tech 55.0 Fund 58.0 Flow 64.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CRMD -56.16% NRIX +20.76% Spread: +76.92 pp (NRIX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CRMD Revenue NRIX Revenue CRMD Op. Margin NRIX Op. Margin Margin Edge
FY2018 $0M N/A -6250.4% N/A CRMD
FY2019 $0M $30M -7416.3% -71.5% NRIX
FY2020 $0M $20M -11378.4% -364.7% NRIX
FY2021 $0M $30M -15417.5% -396.3% NRIX
FY2022 $0M $40M -46819.9% -476.0% NRIX
FY2023 N/A $80M N/A -201.4% NRIX
FY2024 $40M $50M -51.4% -390.5% CRMD
FY2025 $310M $80M 48.2% -340.2% CRMD

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CRMD (4) vs NRIX (6)
Institutional Metric CRMD NRIX Criterion Row Winner
Market Capitalization Scale $384.7M $1.7B Larger Scale NRIX
Trailing P/E Ratio Valuation 2.4x 6.4x Lower Multiple CRMD
Forward P/E Ratio Valuation 49.0x N/M Lower Multiple CRMD
Revenue Growth (YoY) Growth -47.7% +8426.3% Higher Growth NRIX
Operating Margin (TTM) Profitability 41.0% 41.3% Higher Margin NRIX
Net Profit Margin Profitability 15.5% 42.0% Higher Margin NRIX
Return on Equity (ROE) Capital Efficiency 15.3% 44.0% Higher ROE NRIX
52-Week Range Position Momentum 3% ($5โ€“$13) 18% ($12โ€“$28) Stronger Trend NRIX
Beta / 30D Volatility Risk Regime 1.20ฮฒ ยท 107% Vol 0.94ฮฒ ยท 141% Vol Lower Realized Risk CRMD
Unified Institutional Score Composite Signal 53.2 / 100 (HOLD) 51.5 / 100 (HOLD) Higher Composite CRMD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CRMD vs NRIX Buy Guide
CRMD BREAKDOWN
109d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Compressed (<25th %ile)
Live CRMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NRIX BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live NRIX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CRMD nor NRIX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.